Abstract:Activation of Wnt/β‐catenin signalling is frequently observed in many types of cancer including hepatocellular carcinoma (HCC). We recently reported that cullin 4B (CUL4B), a scaffold protein that assembles CRL4B ubiquitin ligase complexes, is overexpressed in many types of solid tumours and contributes to epigenetic silencing of tumour suppressors. In this study, we characterized the function of CUL4B in HCC and investigated whether CUL4B is involved in the regulation of Wnt/β‐catenin signalling. CUL4B and β‐catenin were frequently up‐regulated and positively correlated in HCC tissues. CUL4B activated Wnt/β‐catenin signalling by protecting β‐catenin from GSK3‐mediated degradation, achieved through CUL4B‐mediated epigenetic silencing of Wnt pathway antagonists. Knockdown of CUL4B resulted in the up‐regulation of Wnt signal antagonists such as DKK1 and PPP2R2B. Simultaneous knockdown of PPP2R2B partially reversed the down‐regulation of β‐catenin signalling caused by CUL4B depletion. Furthermore, CRL4B promoted the recruitment and/or retention of PRC2 at the promoters of Wnt antagonists and CUL4B knockdown decreased the retention of PRC2 components as well as H3K27me3. Knockdown of CUL4B reduced the proliferation, colony formation, and invasiveness of HCC cells in vitro and inhibited tumour growth in vivo, and these effects were attenuated by introduction of exogenous β‐catenin or simultaneous knockdown of PPP2R2B. Conversely, ectopic expression of CUL4B enhanced the proliferation and invasiveness of HCC cells. We conclude that CUL4B can up‐regulate Wnt/β‐catenin signalling in human HCC through transcriptionally repressing Wnt antagonists and thus contributes to the malignancy of HCC. Copyright © 2014 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.

CUL4B Promotes Breast Carcinogenesis by Coordinating with Transcriptional Repressor Complexes in Response to Hypoxia Signaling Pathway

CRL4B promotes tumorigenesis by coordinating with SUV39H1/HP1/DNMT3A in DNA methylation-based epigenetic silencing

CRL4B promotes tumorigenesis by coordinating with SUV39H1|[sol]|HP1|[sol]|DNMT3A in DNA methylation-based epigenetic silencing

Increased Cul1 Expression Promotes Melanoma Cell Proliferation Through Regulating P27 Expression

CUL4A Facilitates Hepatocarcinogenesis by Promoting Cell Cycle Progression and Epithelial-Mesenchymal Transition.

Cull Expression Is Increased In Early Stages Of Human Melanoma

CUL4B Activates Wnt/β‐catenin Signalling in Hepatocellular Carcinoma by Repressing Wnt Antagonists

CUL4B Contributes to Cancer Stemness by Repressing Tumor Suppressor Mir34a in Colorectal Cancer

CUL4B Promotes Gastric Cancer Invasion and Metastasis-Involvement of Upregulation of HER2

CRL4B catalyzes H2AK119 monoubiquitination and coordinates with PRC2 to promote tumorigenesis.

NCBP1 promotes the development of lung adenocarcinoma through up-regulation of CUL4B.

Effect of CUL4A on the Metastatic Potential of Lung Adenocarcinoma to the Bone.

Cullin 4B is a Novel Prognostic Marker That Correlates with Colon Cancer Progression and Pathogenesis

CUL4 E3 ligase regulates the proliferation and apoptosis of lung squamous cell carcinoma and small cell lung carcinoma

CUL4B functions as a tumor suppressor in KRAS-driven lung tumors by inhibiting the recruitment of myeloid-derived suppressor cells

The Cul4b/Akt/Beta-Catenin Axis Restricts The Accumulation Of Myeloid-Derived Suppressor Cells To Prohibit The Establishment Of A Tumor-Permissive Microenvironment

CUL4B regulates cancer stem-like traits of prostate cancer cells by targeting BMI1 via miR200b/c.

CUL1 Knockdown Attenuates the Adhesion, Invasion, and Migration of Triple-Negative Breast Cancer Cells Via Inhibition of Epithelial-Mesenchymal Transition

CRL4B Interacts with and Coordinates the SIN3A-HDAC Complex to Repress CDKN1A and Drive Cell Cycle Progression

Cul4B is a Novel Prognostic Marker in Cholangiocarcinoma

Accelerated Hepatocellular Carcinoma Development in CUL4B Transgenic Mice